altretamine has been researched along with Carcinoma, Bronchial in 9 studies
Altretamine: A hexamethyl-2,4,6-triamine derivative of 1,3,5-triazine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Its activity is most marked in ovarian cancer, lymphomas, and carcinoma of the cervix; the drug is also active in bronchogenic carcinoma and carcinoma of the breast." | 1.26 | Hexamethylmelamine. An evaluation of its role in the therapy of cancer. ( Carter, SK; Legha, SS; Slavik, M, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (77.78) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Green, MR | 1 |
| Presant, CA | 1 |
| Metter, GE | 1 |
| Multhauf, P | 1 |
| Bertrand, M | 1 |
| Chang, FF | 1 |
| Klein, L | 1 |
| Rappaport, D | 1 |
| Kendregan, B | 1 |
| Mackie, A | 1 |
| Green, M | 1 |
| Horton, C | 1 |
| Spaulding, M | 1 |
| Silver, RT | 1 |
| Berenberg, J | 1 |
| Kennedy, BJ | 1 |
| Pajak, TF | 1 |
| Comis, R | 1 |
| Broder, LE | 1 |
| Sridhar, KS | 1 |
| Selawry, OS | 1 |
| Charyulu, KN | 1 |
| Rao, RK | 1 |
| Saldana, MJ | 1 |
| Donnelly, EJ | 1 |
| Raub, WA | 1 |
| Miller, CF | 1 |
| Weltz, MD | 1 |
| Heim, WJ | 1 |
| Blom, J | 1 |
| Holoye, PY | 1 |
| DiBella, NJ | 1 |
| Nelson, RA | 1 |
| Norgard, MJ | 1 |
| Legha, SS | 1 |
| Slavik, M | 1 |
| Carter, SK | 1 |
| Bonomi, PD | 1 |
| Pazdur, R | 1 |
| Stolbach, L | 1 |
| Mason, B | 1 |
| Ettinger, D | 1 |
3 trials available for altretamine and Carcinoma, Bronchial
| Article | Year |
|---|---|
Effects of amphotericin B with combination chemotherapy on response rates and on survival in non-small cell carcinoma of the lung.
Topics: Altretamine; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic | 1984 |
Four-drug combination chemotherapy (methotrexate, cyclophosphamide, hexamethylmelamine, and CCNU) for non-small cell bronchogenic carcinoma: a Cancer and Leukemia Group B study.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Clinical Trial | 1983 |
A randomized clinical trial in bronchogenic small-cell carcinoma evaluating alternating maintenance therapy of vincristine, adriamycin, procarbazine, and etoposide (VAPE) with cyclophosphamide, CCNU, and methotrexate (CCM) versus CCM maintenance alone in
Topics: Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinom | 1994 |
6 other studies available for altretamine and Carcinoma, Bronchial
| Article | Year |
|---|---|
Lessons from a time capsule: evolution, not revolution, in therapy for advanced non-small-cell lung cancer.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Non | 2008 |
Six-drug combination chemotherapy for nonresectable bronchogenic carcinoma.
Topics: Adult; Aged; Altretamine; Antineoplastic Agents; Carcinoma, Bronchogenic; Cyclophosphamide; Doxorubi | 1979 |
Management of small-cell bronchogenic carcinoma.
Topics: Altretamine; Antibiotics, Antineoplastic; Brain Neoplasms; Carcinoma, Bronchogenic; Cyclophosphamide | 1978 |
Combination chemotherapy with CCNU (NSC-79037),hexamethylmelamine (NSC-13875) and methotrexate (NSC-740) in advanced bronchogenic carcinoma.
Topics: Aged; Altretamine; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Drug Evaluation; Female; Human | 1975 |
Hexamethylmelamine. An evaluation of its role in the therapy of cancer.
Topics: Altretamine; Animals; Breast Neoplasms; Carcinoma, Bronchogenic; Chemical Phenomena; Chemistry; Drug | 1976 |
Phase II trial of mitomycin, vindesine, and hexamethylmelamine in metastatic non-small cell bronchogenic carcinoma.
Topics: Adult; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; C | 1986 |